🇺🇸 FDA
Patent

US 11712461

Long-acting polypeptide composition for treating atrial fibrillation and its application

granted A61KA61K38/00A61K38/16

Quick answer

US patent 11712461 (Long-acting polypeptide composition for treating atrial fibrillation and its application) held by The First Affiliated Hospital of Xi'an Jiaotong University expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The First Affiliated Hospital of Xi'an Jiaotong University
Grant date
Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00, A61K38/16, A61P, A61P9/06